Woman in lab working

    Research

    The Alliance’s mission is to end colorectal cancer in our lifetime. By supporting innovative colorectal cancer research by top doctors and scientists, we take important steps toward realizing our vision — a world free of this disease.

    By the numbers

    1,000

    We've invested 1,000 hours gaining patient insights.

    $5M

    We've invested nearly $5 million in innovative research.

    75

    We work with 75 partner physicians and scientists.

    doctor with Petri dish

    How we fund innovative colorectal cancer research

    Our research program is a critical driving force in our mission to end colorectal cancer in our lifetime. We've invested nearly $5 million in colorectal cancer research, including nearly $3 million as early-stage grants to innovative researchers. Learn more about how our funding mechanisms guide our investments in colorectal cancer research.

    How we fund research

    Funding innovative colorectal cancer research

    microscope with slide closeup

    Projects we've funded

    By funding the most innovative colorectal cancer research studies, we take important steps toward realizing our vision—a world free of colorectal cancer.

    books on shelf blurry

    Research library

    Our research library is your one-stop source to find Alliance-led progress reports, publications, presentations, and more based on our recent work in colorectal cancer research.

    Providing leadership in colorectal cancer research

    By convening scientific community leaders and patients together to advance and build knowledge, we are more efficiently addressing critical issues for patients’ direct benefit.

    Woman cuddling bear in bed

    Support colorectal cancer research

    Thanks to our generous supporters and the work of researchers all over the world, more survivors are beating colorectal cancer than ever before. However, we still have a long way to go. We need:

    • Breakthroughs for advanced colorectal cancer
    • Less toxic and more effective cancer treatments,
    • Better techniques to diagnose and treat young onset colorectal cancer
    • A better understanding of what motivates people to get screened earlier and detect or prevent this unique cancer.

    Let’s work together to ensure that more families beat this cancer.

    Donate for research
    david_fenstermacher

    "Colorectal cancer is the second leading cause of cancer death in the U.S., with an increasing rise in early onset disease, or being diagnosed before the age of 50. To change the trajectory of this disease and improve patient outcomes, the Alliance is committed to funding research that leads to new treatments and improved therapies, novel methods in diagnostics, prognostics, and monitoring response to therapies, and studies focused on health equity in screening and care. The Alliance supports studies across the spectrum of basic, translational and clinical research as the promise of managing and curing colorectal cancer is within sight and research funding is desperately needed to realize our goal of eradicating colorectal cancer in our lifetime."

    David A. Fenstermacher, Ph.D.
    Senior Director of Research and Medical Affairs

    Top resources

    View all resources
    An image of the back of a T-shirt, which has written on it, "Make cancer an election issue."

    Be heard this November: The Cancer Promise

    Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.

    Last updated
    The United States Capitol Building in Washington, D.C.

    Alliance supports the Clinical Trials Modernization Act

    This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.

    Last updated